[The cyclophosphamide treatment of glomerulonephritis patients].
An analysis is presented of direct results of monotherapy with cyclophosphamide of 70 patients suffering of acute and chronic glomerulonephritis. The treatment proved effective in 10% of patients. It was established that the initially reduced levels of immunoglobulins G and A in the blood serum of patients with glomerulonephritis are a prognosis-positive factor for the use of cyclophosphamide.